Elevance Health (ELV) Fundamental Analysis: Revenue, Earnings & Valuation

4.82 / 10

Netural

Fundamentally, ELV scores 4.8/10, indicating moderate strength. Positive factors include PB‑ROE and cash‑flow‑to‑revenue ratio, while Revenue‑MV and cash‑flow‑per‑share growth lag. The mixed fundamentals suggest cautious optimism.

Analysis Checks(3/10)

Revenue-MV

Value2.15

Score1/3

Weight9.53%

1M Return1.77%

Net cash flow from operating activities per share (YoY growth rate %)

Value-23.88

Score0/3

Weight-7.01%

1M Return-1.30%

Net cash flow from operating activities / Operating revenue (%)

Value2.15

Score2/3

Weight10.73%

1M Return1.67%

PB-ROE

Value-0.41

Score3/3

Weight45.32%

1M Return6.13%

Basic earnings per share (YoY growth rate %)

Value-2.05

Score1/3

Weight4.38%

1M Return0.67%

Total profit (YoY growth rate %)

Value-15.11

Score2/3

Weight23.02%

1M Return3.45%

Net cash flow from operating activities (YoY growth rate %)

Value-26.14

Score0/3

Weight-12.03%

1M Return-2.21%

Diluted earnings per share (YoY growth rate %)

Value-1.83

Score1/3

Weight4.65%

1M Return0.72%

Asset-MV

Value-0.55

Score1/3

Weight8.94%

1M Return1.65%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value-5.32

Score1/3

Weight12.47%

1M Return1.90%

Is ELV fundamentally strong?

ELV scores 4.82/10 on fundamentals and holds a Fair valuation at present. Backed by its 13.25% ROE, 2.84% net margin, 11.54 P/E ratio, 1.48 P/B ratio, and -2.05% earnings growth, these metrics solidify its Netural investment rating.